Bromination of deoxycytidine by eosinophil peroxidase: A mechanism for mutagenesis by oxidative damage of nucleotide precursors

  • Jeffrey P. Henderson
    Departments of Medicine, Pediatrics, Radiology, and Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110; and Research Service, Veterans Administration Medical Center and Department of Internal Medicine, University of Iowa, Iowa City, IA 52241
  • Jaeman Byun
    Departments of Medicine, Pediatrics, Radiology, and Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110; and Research Service, Veterans Administration Medical Center and Department of Internal Medicine, University of Iowa, Iowa City, IA 52241
  • Michelle V. Williams
    Departments of Medicine, Pediatrics, Radiology, and Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110; and Research Service, Veterans Administration Medical Center and Department of Internal Medicine, University of Iowa, Iowa City, IA 52241
  • Michael L. McCormick
    Departments of Medicine, Pediatrics, Radiology, and Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110; and Research Service, Veterans Administration Medical Center and Department of Internal Medicine, University of Iowa, Iowa City, IA 52241
  • William C. Parks
    Departments of Medicine, Pediatrics, Radiology, and Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110; and Research Service, Veterans Administration Medical Center and Department of Internal Medicine, University of Iowa, Iowa City, IA 52241
  • Lisa A. Ridnour
    Departments of Medicine, Pediatrics, Radiology, and Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110; and Research Service, Veterans Administration Medical Center and Department of Internal Medicine, University of Iowa, Iowa City, IA 52241
  • Jay W. Heinecke
    Departments of Medicine, Pediatrics, Radiology, and Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110; and Research Service, Veterans Administration Medical Center and Department of Internal Medicine, University of Iowa, Iowa City, IA 52241

書誌事項

公開日
2001-02-06
DOI
  • 10.1073/pnas.98.4.1631
公開者
Proceedings of the National Academy of Sciences

この論文をさがす

説明

<jats:p>Oxidants generated by eosinophils during chronic inflammation may lead to mutagenesis in adjacent epithelial cells. Eosinophil peroxidase, a heme enzyme released by eosinophils, generates hypobromous acid that damages tissue in inflammatory conditions. We show that human eosinophils use eosinophil peroxidase to produce 5-bromodeoxycytidine. Flow cytometric, immunohistochemical, and mass spectrometric analyses all demonstrated that 5-bromodeoxycytidine generated by eosinophil peroxidase was taken up by cultured cells and incorporated into genomic DNA as 5-bromodeoxyuridine. Although previous studies have focused on oxidation of chromosomal DNA, our observations suggest another mechanism for oxidative damage of DNA. In this scenario, peroxidase-catalyzed halogenation of nucleotide precursors yields products that subsequently can be incorporated into DNA. Because the thymine analog 5-BrUra mispairs with guanine in DNA, generation of brominated pyrimidines by eosinophils might constitute a mechanism for cytotoxicity and mutagenesis at sites of inflammation.</jats:p>

収録刊行物

被引用文献 (12)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ